Mepact (mifamurtide) / Medison, Takeda  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mepact (mifamurtide) / Takeda
NCT00631631: Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma

Completed
N/A
205
US
Mifamurtide (L-MTP-PE), Liposomal Muramyl Tripeptide Phosphatidyl Ethanolamine
Millennium Pharmaceuticals, Inc.
Osteosarcoma
10/12
10/12
NCT01194284: Surveillance Study of Patients With Newly Diagnosed Osteosarcoma

Terminated
N/A
25
Europe
Mifamurtide, MEPACT
Millennium Pharmaceuticals, Inc.
Osteosarcoma
12/13
12/13
Micros, NCT03737435: Tumor Microenvironment in Patients With Localized Osteosarcoma Treated With Mifamurtide: a Translational Study

Recruiting
N/A
80
Europe
Istituto Ortopedico Rizzoli
Localized Osteosarcoma
06/24
06/24

Download Options